- Home
- DIBS vs TARA Comparison
DIBS vs TARA Comparison
Compare DIBS & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIBS
- TARA
- Stock Information
- Founded
- DIBS 2000
- TARA N/A
- Country
- DIBS United States
- TARA United States
- Employees
- DIBS 284
- TARA N/A
- Industry
- DIBS Catalog/Specialty Distribution
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DIBS Consumer Discretionary
- TARA Health Care
- Exchange
- DIBS Nasdaq
- TARA Nasdaq
- Market Cap
- DIBS 101.5M
- TARA 118.1M
- IPO Year
- DIBS 2021
- TARA N/A
- Fundamental
- Price
- DIBS $2.80
- TARA $3.14
- Analyst Decision
- DIBS Hold
- TARA Strong Buy
- Analyst Count
- DIBS 1
- TARA 6
- Target Price
- DIBS N/A
- TARA $19.80
- AVG Volume (30 Days)
- DIBS 49.1K
- TARA 151.2K
- Earning Date
- DIBS 11-07-2025
- TARA 11-11-2025
- Dividend Yield
- DIBS N/A
- TARA N/A
- EPS Growth
- DIBS N/A
- TARA N/A
- EPS
- DIBS N/A
- TARA N/A
- Revenue
- DIBS $88,640,000.00
- TARA N/A
- Revenue This Year
- DIBS $3.69
- TARA N/A
- Revenue Next Year
- DIBS $6.79
- TARA N/A
- P/E Ratio
- DIBS N/A
- TARA N/A
- Revenue Growth
- DIBS 3.21
- TARA N/A
- 52 Week Low
- DIBS $2.30
- TARA $1.60
- 52 Week High
- DIBS $5.00
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- DIBS 56.46
- TARA 49.92
- Support Level
- DIBS $2.68
- TARA $3.05
- Resistance Level
- DIBS $2.90
- TARA $3.30
- Average True Range (ATR)
- DIBS 0.11
- TARA 0.14
- MACD
- DIBS 0.01
- TARA 0.00
- Stochastic Oscillator
- DIBS 64.29
- TARA 35.71
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).